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OBJECTIVES This study evaluated the long-term reliability of an implantable cardioverter defibrillator
(ICD) lead to determine the incidence, clinical presentation, and management of lead failure.
BACKGROUND Despite recent advances in ICD technology, the long-term reliability of ICD leads remains
a significant problem.
METHODS Concern about long-term reliability of coaxial polyurethane ICD leads caused us to
systematically study all patients implanted with Medtronic (Minneapolis, Minnesota) 6936
lead at our institution. We performed follow-up of 74 patients with 76 ICD leads that were
implanted from February 28, 1995 to September 8, 1997. Thirty-seven patients underwent
routine clinical ICD follow-up testing and ventricular fibrillation induction to determine the
status of their ICD lead after a mean follow-up of 68.6  8.2 months.
RESULTS The lead survival analysis shows a cumulative failure probability of 37% (confidence interval,
24% to 54%) at 68.6 months. Six patients demonstrated a previously undescribed mode of
ICD lead failure: prolonged oversensing immediately after shock therapy. The use of short
interval counters to monitor nonphysiologic R-R intervals and the measurement of ring-to-
coil impedance detected early lead failures in five patients.
CONCLUSIONS This analysis shows: 1) problems with ICD leads may not become apparent until late during
follow-up and may become a significant late problem, 2) a “signature” mode of lead failure for
the 6936 consisting of oversensing of electrical noise following shocks, 3) early detection of
lead failure with a short interval counter algorithm or measurement of ring-to-coil impedance
may be clinically useful. (J Am Coll Cardiol 2003;41:73–80) © 2003 by the American
College of Cardiology Foundation
The implantable cardioverter defibrillator (ICD) has be-
come the standard of care for treatment of patients with
life-threatening or potentially life-threatening ventricular
tachyarrhythmias (1,2). With the increased implantation of
ICDs, concern about the long-term reliability of ICD leads
has become an increasing concern (3–18). Implantable
cardioverter defibrillator leads are significantly more com-
plex than pacemaker leads and, as a result, may be inherently
more susceptible to failure. Long-term reliability of ICD
leads has become the “Achilles heel” of defibrillator therapy.
Implantable cardioverter defibrillator lead dysfunction
may result in failure of the ICD to deliver therapy for
ventricular tachycardia and, thus, result in syncope or
sudden death. Lead dysfunction may also result in inappro-
priate shocks and subsequent psychological distress, need
for operative revision or removal resulting in additional
morbidity and mortality, and increased health care costs.
Implantable cardioverter defibrillator lead failure may ini-
tially be clinically silent, and early detection before clinical
presentation with inappropriate shocks or sudden death is
important. Patients with ICD leads demonstrating an in-
creased failure rate also need closer follow-up. Finally,
lessons learned from ICD leads with high failure rates may
help engineers design better and more reliable leads.
We noted a unique mode of failure of an ICD lead during
clinical follow-up that led us to perform a systematic
evaluation of all patients at our institution with this lead.
The purpose of this investigation was to determine the
mode, incidence, and time course of failure of patients with
the Medtronic 6936 ICD lead. Finally, we sought to
determine if any electrophysiologic measurements could
predict the development of lead failure.
METHODS
The study population consisted of 74 patients who under-
went a total of 76 Medtronic 6936 ICD lead implantations
from February 28, 1995 to September 8, 1997. The 6936
defibrillation lead is a coaxial, tripolar active fixation lead
with true bipolar sensing. It is made with a polyurethane
55D insulation covering the inner conductor and a polyure-
thane 80A covering the middle conductor and serving as the
outer insulation (Fig. 1). Patients underwent implantation
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of an ICD at the Medical College of Virginia for an
accepted clinical indication. Routine ICD testing of pacing
and sensing thresholds and defibrillation thresholds (DFT)
was performed at the time of implantation. Patients were
followed in ICD clinic every three to six months at which
time they underwent routine device evaluation. Evaluation
in ICD clinic consisted of interrogation of the ICD with
retrieval of all stored events and intracardiac electrograms,
measurement of pacing and sensing thresholds, measure-
ment of lead impedance, recordings of real time electro-
grams, evaluation of nonsustained ventricular tachycardia
counters assessing nonphysiologic events, and measurement
of lead impedance and noninvasive telemetry of shocking
impedance. Routine annual ICD testing of DFTs was not
performed. Each patient was seen within 24 to 48 h after
delivery of ICD therapy to have the device interrogated, and
lead impedances and pacing and sensing thresholds
checked.
All surviving leads underwent a follow-up evaluation of
their ICD system during the time period of July 2001 to
February 2002, which consisted of induction of ventricular
fibrillation for determining DFT and high-voltage imped-
ance, measurement of pacing and sensing thresholds, mea-
surement of lead impedances, recording of real-time elec-
trograms, and mechanical maneuvers (e.g., isometric
exercises, etc.) to provoke evidence of sensing problems.
Additionally, with the use of custom translation software, all
patients with Medtronic GEM models (7227, 7229, 7271,
7273) underwent telemetry of the sensing integrity counter,
which collects data on the number of short R-R ventricular
intervals between follow-up appointments. The short inter-
val or sensing integrity counter tracks the number of
nonpaced R-R intervals less than 140 ms between clinic
visits (19). The translation software also stores the results of
ring-to-right-ventricle coil lead impedance measurements
for the past year. This measurement reports the minimal
value every week based on daily measurements. In a true
bipolar lead, normal measurements are 26 to 40 . In an
integrated bipolar lead, where the ring is the coil, the
normal measurement is approximately 4 . In theory, as the
inner insulation fails on a bipolar ICD lead, the ring-to-coil
impedance is expected to fall.
Patients who moved out of state had all follow-ups done
by their local electrophysiologist except for ventricular
fibrillation induction, and the results were forwarded to one
of the investigators for review. All patients who were
deceased had their medical records reviewed and their
family and local doctors contacted to obtain details about
the events at the time of death.
Oversensing was defined as the detection of inappropriate
electrical signals by the pulse generator’s sense amplifier.
Undersensing was defined as the failure to sense a signal
visible on the surface electrocardiogram. Metal ion oxida-
tion (MIO) was defined when examination of the pacing
leads by the manufacturer confirmed this. Returned product
analysis consists of electrical testing to determine the con-
tinuity of the conductor coils, and microscopic examination
to assess the presence of insulation breaching. Metal ion
oxidation is a type of insulation failure that occurs with
polyurethane leads caused by degradation of the polyure-
thane on the inside of the lead initiated by the migration of
ions from the conductor wire.
Abbreviations and Acronyms
CI  confidence interval
DFT  defibrillation threshold
ICD  implantable cardioverter defibrillator
MIO  metal ion oxidation
Figure 1. Schematic diagram of Medtronic 6936 coaxial tripolar implantable cardioverter defibrillator lead. HVB  high voltage distal coil; P/S 
pace/sense.
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Statistics. All variables were reported as mean  SD.
Kaplan-Meier product limit method was used to compute
survival estimates of chronic lead performance of the 6936
leads. The Greenwood method was used to compute the
95% confidence interval (CI) for survival at each failure time
of the leads. The log-rank method was used to compare the
6936 lead survival curves for different vein access methods.
Continuous variables between groups were compared using
the t test.
RESULTS
We studied 74 patients with 76 ICD leads. The mean age
was 62  16 years. Fifty-eight patients were men, 16 were
women. The mean ejection fraction was 34  11%. Sixty-
five percent of patients had an ischemic cardiomyopathy,
23% had a nonischemic cardiomyopathy, and 12% had other
forms of heart disease. Twenty patients died during a mean
follow-up of 2.9  1.5 years (range, 0.1 to 5.2 years).
Fourteen patients died from congestive heart failure, five
patients died from noncardiac causes, and the cause of death
is unknown in one patient. None of the deaths were related
to ICD lead failure.
Clinical follow-up. From May 1995 to July 2001, all ICD
patients underwent routine follow-up. During this period of
time, ICD lead failures were detected in 14 patients. The
failure mechanism(s) detected in these patients are shown in
Figure 2. Of the 14 patients who had evidence of ICD lead
failure, six patients presented with postshock oversensing,
one patient presented with noise on the rate/sensing elec-
trogram during sinus rhythm, one patient presented with
high pacing impedance, two patients presented with high
shocking impedance, one patient presented with poor sens-
ing of R waves during sinus rhythm, one patient presented
with low pacing impedance (200 ), and two patients
presented with abnormal impedances for both the rate/
sensing and high-voltage measurements. Four additional
patients had their leads removed because of infection or
heart transplantation.
Unique mode of failure. A unique mode of ICD lead
failure was noted during clinical follow-up. A total of six
patients demonstrated oversensing after an appropriate
shock (n  2) for ventricular tachycardia and after an
inappropriate shock (n  4) (Fig. 3). In each case, multiple
additional inappropriate shocks were delivered.
Figure 2. Flow chart for all patients undergoing implantation of the Medtronic 6936 implantable cardioverter defibrillator (ICD) lead. Current clinical
status for all ICD leads is summarized. DFT  defibrillation threshold; EGM  electrograms.
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Electrophysiologic testing. From June 2001 until July
2002, 37 patients had ICD follow-up testing. Twenty-six
patients had normal results of follow-up ICD testing (Fig.
2). In no patient did provocative maneuvers demonstrate
evidence of lead failure. Four patients had increases in
high-voltage impedance of 28% to 31% and are being
followed up every three months. Two patients had normal
lead measurements, but were unable to be defibrillated by
their ICD system due to increased DFTs. The results of
statistical comparisons between patients at follow-up with
ICD lead failure and those without ICD lead failure are
shown in Table 1. Changes in pacing or sensing thresholds
or lead impedance were not helpful in predicting or detect-
ing lead problems.
The time course of lead failures is shown by the Kaplan-
Meier curves in Figure 4. The cumulative lead survival was
98.6% at one year (CI: 90.7% to 99.8%), 95.8% at two years
(CI: 87.5% to 98.6%), 94.2% at three years (85.3% to
97.8%), 90.7% at four years (CI: 80.3% to 95.7%), and
80.9% at five years (CI: 68.0% to 89.1%). The estimated
cumulative failure probability at 68.6 months is 37% (CI:
24% to 54%). The survival of 6936 ICD leads implanted by
a cephalic vein cutdown approach or by a subclavian access
approach showed no difference (p  0.972).
A total of five failures were detected during electrophysi-
ologic testing and additional follow-up. Two lead failures
were detected by follow-up ICD testing. One patient
demonstrated oversensing after an appropriate ventricular
tachycardia shock and increasing numbers of nonsustained
ventricular tachycardia episodes (140 to 160 ms), and one
Figure 3. Stored intracardiac electrograms from a patient presenting with sustained monomorphic ventricular tachycardia (rate, 200 beats/min) associated
with lightheadedness and dizziness. The patient received an appropriate shock for ventricular tachycardia, which terminated this arrhythmia, then received
a total of five additional inappropriate shocks due to oversensing during sinus rhythm immediately after appropriate therapy was delivered.
Table 1. Electrophysiologic Variables of Patients With and
Without ICD Lead Failures
Electrophysiologic
Parameters
Follow-Up
Patients
(n  32)
Failure
Patients
(n  5) p Value
Energy (J) 1.35  0.77 0.67  0.49 0.07
R-wave (mV) 10.47  3.05 13.2  4.21 0.09
Pacing impedance () 845  353 802  154 0.79
HV impedance () 58.0  7.7 65.0  4.2 0.06
HV  high voltage; ICD  implantable cardioverter defibrillator.
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patient showed noise after cardioversion in sinus rhythm
and a decrease in ring-to-coil impedance.
Three additional failures were detected by routine clinical
follow-up. In these patients short interval counters and/or
ring-to-coil impedance measurements predicted lead failure
(Fig. 5). One patient had a short interval counter 2,400
and a decrease in ring-to-coil impedance from 30 to 9  in
the period five months before the time of ICD testing. One
month later the short interval counter was 10,000, and a
decrease in coil-to-tip impedance was noted. One episode of
oversensing was noted, but no therapy was delivered.
Another patient had a variable ring-to-coil impedance
with a normal short interval count. Three months later the
short interval count reached 3,700, and the ring-to-coil
impedance dropped from 30 to 8 . No episodes of
ventricular tachycardia were detected. This patient under-
went ICD lead extraction.
One patient had normal ICD testing, but one week later
the short interval count reached 3,500. One month later
oversensing resulting in six inappropriate shocks, and lead
extraction was performed.
The results of lead analysis for the seven returned leads
are shown in Table 2. There was an excellent correlation
between the presumed clinical diagnosis and the results of
analysis of the failed ICD leads. Six of the seven patients
had evidence of MIO from lead analysis, and this was
predicted based on the finding of oversensing during sinus
rhythm.
Management of ICD lead-related problems. Fifteen pa-
tients underwent laser lead extraction and replacement with
a new ICD lead. Two patients had their ICD leads capped
and a new ICD lead implanted. One patient had a new
sensing lead implanted, and one patient had a new ICD
system implanted in the right pectoral region.
DISCUSSION
The major findings from our study are that transvenous
ICD lead failure: 1) may occur at any time after implanta-
tion with a high cumulative failure rate requiring more
careful follow-up and testing; 2) a new mode of lead failure,
noise after a shock, may be a specific sign of coaxial
polyurethane ICD lead failure; and 3) measurements from
short interval counters or ring-to-coil impedance may be
helpful for detecting problematic leads before lead failure is
detected by inappropriate shocks. The Medtronic 6936
ICD lead can be safely removed by laser lead extraction.
The high failure rate of the Medtronic 6936 ICD lead
observed in our study is similar to that reported by others,
including the manufacturer (10,18,20). Luria et al. (10) and
Figure 4. Kaplan-Meier survival curve for the Medtronic 6936 implantable cardioverter defibrillator lead.
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Figure 5. Two graphs demonstrating examples of patients with measurement of implantable cardioverter defibrillator (ICD) ring-to-coil impedance with
translation software. (A) A drop in lead impedance (down arrow) precedes an inappropriate detection (up arrow) by a period of over 20 weeks. (B) A drop
in lead impedance (down arrow) preceded ICD lead failure and need for lead extraction by almost one year. Lead extraction was performed in this patient
before delivery of inappropriate shocks. Both of these patients underwent microscopic examination of the leads confirming the presence of metal ion
oxidation breaching. VF  ventricular fibrillation.
Hauser et al. (18) have both reported failure rates for the
6936 and other similar coaxial polyurethane ICD leads of
close to 20% at four years. The major presentation of lead
failure was due to oversensing in all three studies. The
reliability of this estimate is decreased due to inconsistent
follow-up and loss of patients over time to death from heart
failure and other causes. It is likely that we have also
underestimated the number of lead failures, as follow-up
testing has identified three patients with high shocking lead
impedance undergoing intensified follow-up.
Careful study of the Kaplan-Meier curve shows that the
increasing failure rate is noted primarily during long-term
follow-up. A lead database that follows large numbers of
patients until death is necessary to detect lead problems that
occur primarily during late follow-up or with such a low
incidence that investigators with small numbers of patients
may not detect a problem. It is possible with continued
long-term follow-up that many ICD leads will demonstrate
more late problems.
Failure of pacing or defibrillation leads due to breakdown
of polyurethane is not a new finding (21–23). Polyurethane
breakdown, in most cases due to MIO, has been shown to
be the mode of failure for most coaxial polyurethane pacing
leads. Polyurethane polymers and the production of com-
plex coaxial leads seem to be the combination that results in
the highest incidence of lead failures. The middle insulation
layer of the 6936 is 80A polyurethane, which is the same
polyurethane that was used to manufacture Medtronic 4004
and 4012 leads. The insulation degradation presumably
occurs over time in high-stress areas.
This study identifies a new presentation for polyurethane
lead failure. In two patients appropriate shock therapy was
delivered for ventricular tachycardia, followed by oversens-
ing for several seconds immediately after shock. In four
patients oversensing was also demonstrated intermittently
during sinus rhythm and after an inappropriate shock. A
possible explanation is this mode of failure represents a
noncontact defect between the pace/sense ring conductor
and the right ventricular high voltage conductor. It is likely
that this problem remains clinically “silent” and is not
exposed until a high-voltage shock is delivered. After a
shock, the pace/sense conductor is hyperpolarized, and
disturbance of the polarization potential due to cyclical
loading during the cardiac cycle leads to electrical transients
resulting in redetection and a succession of shocks. This
polarization potential may linger for 10 min or longer. This
can be confirmed by measurement of a decrease in the
ring-coil impedance. Another possible cause for these ob-
servations is that the metal-to-metal contact occurs after
powerful muscle contractions where one conductor has a
large amount of postshock polarization voltage. The ex-
posed conductors then generate high-voltage artifacts as
they scrape together. This mode of failure may be a
“signature” for 6936-lead failure and had not been previ-
ously reported.
The short interval counter or sensing integrity counter
keeps track of the number of short nonpaced intervals less
than 140 ms. The programmer displays the number of short
ventricular intervals that have occurred since the stored data
was cleared or the device implanted. This diagnostic proved
useful for predicting early lead failure. If the use of the short
interval counter to predict lead failure is confirmed in
prospective studies, it may be particularly useful for diag-
nosing lead failures before they become clinically manifest.
Detection of a high short interval counter could lead to early
lead extraction or closer follow-up. While ring-to-coil
impedance is the earliest method of detection, it may not
provide a complete assessment of lead integrity. However, a
ring-to-coil impedance drop confirmed subsequently by a
rise in short interval counter data may be a useful indicator
of MIO breach.
Study limitations. Our present study does provide some
useful practical information that can be used to guide
follow-up of ICD patients. We feel that given the high
incidence of late failure of patients with the 6936 ICD lead
should undergo more frequent clinic follow-up visits, espe-
Table 2. Correlation of Clinical Presentation With Returned Lead Analysis
Returned
Lead
Clinical
Presentation Clinical Diagnosis
Primary Mode of
Failure
Secondary Mode
of Failure
1 High lead impedance, oversensing,
inappropriate therapy
Subclavian crush/conductor fracture Several conductors
fractured/crushed
Outer insulation
“environmental stress
cracking” (ESC)
2 High lead impedance, oversensing,
inappropriate therapy
MIO Middle insulation
breach MIO
All insulators cosmetic
MIO
3 High lead impedance, oversensing MIO Middle insulation
breach MIO
All insulators cosmetic
MIO
4 Oversensing, inappropriate therapy MIO Middle insulation
breach MIO
Outer insulation
cosmetic (ESC)
5 Oversensing MIO Middle insulation
breach MIO
Outer insulation
cosmetic MIO
6 Oversensing MIO Middle insulation
breach MIO
Inner insulation
cosmetic MIO
7 Oversensing, inappropriate therapy MIO Middle insulation
breach MIO
Outer insulation
cosmetic (ESC)
ESC  environmental stress cracking; MIO  metal ion oxidation.
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cially looking for episodes of nonsustained ventricular
tachycardia with nonphysiologic intervals. In patients with
ICD, pulse generators capable of measuring short interval
counters or lead-to-coil impedance, review of this data
should be useful to predict eventual ICD lead failure.
Routine ventricular fibrillation induction, perhaps on a
yearly basis, may also be worthwhile to look for postshock
oversensing. We do not perform routine chest radiography
during follow-up, so we cannot comment on routine chest
radiograph tests to detect lead failures. Changes in pacing or
sensing thresholds did not predict lead failures, but the
small number of patients with lead failures at the time of
testing and the use of different device models calculating
impedance in different ways made that data difficult to
interpret.
Our findings raise important issues regarding the costs
and alternative approaches to patients who have “prophy-
lactic” ICDs. Many of these patients will have a relatively
long life span where lead problems (particularly in patients
who have multiple transvenous leads) may become a prom-
inent concern. Lead problems result in considerable mor-
bidity and add substantially to health care costs. Ideally,
ICD leads with excellent long-term reliability will help
leads, but the complex structure and requirements for such
leads likely limit the ease with which this goal may be
achieved. Consideration of novel approaches to these pa-
tients such as “leadless” ICDs deserves further attention
(24).
In summary, ICD lead failures may occur late during
follow-up after the lead is implanted. A new mode of ICD
lead failure is described, as well as the measurements from
the short interval counter and the ring-to-coil impedance, to
predict lead failure. Finally, this study highlights the im-
portance of a skilled electrophysiologist performing contin-
ued careful clinical follow-up of ICD leads to determine
lead long-term reliability.
Reprint requests and correspondence: Dr. Kenneth A. Ellen-
bogen, Medical College of Virginia, P.O. Box 980053, Richmond,
Virginia 23398-0053. E-mail: kellenbogen@pol.net.
REFERENCES
1. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines
for implantation of cardiac pacemakers, and antiarrhythmic devices:
executive summary—a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines.
Circulation 1998;97:1325–35.
2. The Antiarrhythmics Versus Implantable Defibrillators (AVID) In-
vestigators. A comparison of antiarrhythmic drug therapy with im-
plantable defibrillators in patients resuscitated from near fatal ventric-
ular arrhythmias. N Engl J Med 1997;337:1576–83.
3. Stambler BS, Wood MA, Damiano RJ, Greenway PS, Smutka ML,
Ellenbogen KA. Sensing/pacing lead complications with a newer
generation implantable cardioverter-defibrillator: a worldwide experi-
ence from the Guardian ATP 4210 clinical trial. J Am Coll Cardiol
1994;23:123–32.
4. Schwartzman D, Nallamothu N, Callans DJ, Preminger MW, Got-
tlieb CD, Marchlinski FE. Postoperative lead-related complications in
patients with nonthoractomy defibrillation lead systems. J Am Coll
Cardiol 1995;25:776–86.
5. Gahy GJ, Kleman JM, Wilkoff BL, Morant VA, Pinski SL. Low
incidence of lead related complications associated with non-
thoracotomy implantable cardioverter defibrillator systems. Pacing
Clin Electrophysiol 1995;18:172–8.
6. Lawton JS, Ellenbogen KA, Wood MA, et al. Sensing lead-related
complications in patients with transvenous implantable cardioverter-
defibrillators. Am J Cardiol 1996;78:647–51.
7. Gold MR, Peters RW, Johnson JW, Shorofsky SR. Complications
associated with pectoral implantation of cardioverter defibrillators:
world-wide jewel investigators. Pacing Clin Electrophysiol 1997;20:
208–11.
8. Degertu FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR.
Sensing lead failure in implantable defibrillators: a comparison of two
commonly used leads. J Cardiovasc Electrophysiol 2000;11:21–4.
9. Tyers GF, Sanders R, Jacqmein W. Reliability of coated wire defibril-
lation leads. Pacing Clin Electrophysiol 1999;22:174–8.
10. Luria D, Glikson M, Brady PA, et al. Predictors and mode of
detection of transvenous lead malfunction in implantable defibrillators.
Am J Cardiol 2001;87:901–4.
11. Kron J, Herre J, Renfroe EG, et al. Lead- and device-related
complications in the antiarrhythmics versus implantable defibrillators
trial. Am Heart J 2001;141:92–8.
12. Mehta D, Nayak HM, Singson M, et al. Late complications in
patients with pectoral defibrillator implants with transvenous defibril-
lator lead systems: high incidence of insulation breakdown. Pacing
Clin Electrophysiol 1998;21:1893–900.
13. Lawton JS, Wood MA, Gilligan DM, Stambler BS, Damiano RJ Jr.,
Ellenbogen KA. Implantable transvenous cardioverter defibrillator
leads: the dark side. Pacing Clin Electrophysiol 1996;19:1273–8.
14. Korte T, Jung W, Spehl S, et al. Incidence of ICD lead related
complications during long-term follow-up: comparison of epicardial
and endocardial electrode systems. Pacing Clin Electrophysiol 1995;
18:2053–61.
15. Bracke FALE, Meijer A, van Gelder LM. Malfunction of endocardial
defibrillator leads and lead extraction: where do they meet? Europace
2002;4:19–24.
16. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral
implantable cardioverter-defibrillator: Active Canadian investigators.
J Am Coll Cardiol 1996;28:400–10.
17. Roelke M, O’Nunain SS, Osswald S, Garan H, Harthorne JW,
Ruskin JN. Subclavian crush syndrome complicating transvenous
cardioverter defibrillator systems. Pacing Clin Electrophysiol 1995;18:
973–9.
18. Hauser RG, Cannom D, Hayes DL, et al. Long-term structural failure
of coaxial polyurethane implantable cardioverter defibrillator leads.
Pacing Clin Electrophysiol 2002;25:879–82.
19. Gunderson B, Wood N, Pearson A, Wang W, Olson W. A new
sensing integrity indicator for ventricular pace/sense leads. Pacing Clin
Electrophysiol 2000;23:591.
20. Medtronic Inc. ICD Lead Survival Analysis. Tachyarrhythmia Prod-
uct Performance Report. 2nd ed. Fridley, MN: Medtronic, 2001.
21. Hayes DL, Graham KJ, Irwin M, et al. Multicenter experience with a
bipolar tined polyurethane ventricular lead. Pacing Clin Electrophysiol
1995;18:999–1004.
22. Antonelli D, Rosenfeld T, Freedberg NA, Palma E, Gross JN,
Furman S. Insulation lead malfunction: is it a matter of insulation
coating, venous approach, or both? Pacing Clin Electrophysiol 1998;
21:418–21.
23. Mond HG. Engineering and clinical aspects of pacing leads. In:
Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical Cardiac
Pacing and Defibrillation. Philadelphia, PA: WB Saunders Company,
2000:127–50.
24. Bardy GH, Cappato R, Smith WM, et al. The totally subcutaneous
ICD system (the S-ICD) (abstr). Pacing Clin Electrophysiol 2002;24:
578.
80 Ellenbogen et al. JACC Vol. 41, No. 1, 2003
Long-Term Failure of ICD Leads January 1, 2003:73–80
